Wo Bi Shi Yao Shen (2018)

Wo Bi Shi Yao Shen
Theatrical Performance
Domestic Box Office $6,752Details
International Box Office $451,176,640
Worldwide Box Office $451,183,392
Further financial details...

Synopsis

When a father struggling to keep custody of son, keep his business afloat and keep his own father alive, is given a chance to profit off of overseas pharmaceutical smuggling, he jumps at the chance. But what follows is one man’s profound evolution from what it is to make money to what it is to make a difference.

Metrics

Opening Weekend:$3,238 (48.0% of total gross)
Legs:2.09 (domestic box office/biggest weekend)
Domestic Share:0.0% (domestic box office/worldwide)
Theater counts:2 opening theaters/2 max. theaters, 2.0 weeks average run per theater
Infl. Adj. Dom. BO $8,815

Movie Details

Domestic Releases: August 9th, 2019 (Limited) by China Lion Film Distribution, released as Dying to Survive
International Releases: June 30th, 2018 (Wide) (China)
MPA Rating: Not Rated
Running Time: 96 minutes
Geographical setting: China, India
Plot point: Cancer, Medical and Hospitals, Pharmaceuticals, Smuggler, Terminal Illness
Source material: Inspired by a True Story
Subgenre: Comedy Drama
Source:Original Screenplay
Genre:Drama
Production Method:Live Action
Creative Type:Contemporary Fiction
Production/Financing Companies: Dirty Monkey Films Group, Huanxi Media Group Limited, Beijing Universe Starlight Culture Media Company, Beijing Talent International Film Co
Production Countries: China
Languages: Mandarin

Weekend Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Aug 9, 2019 61 $3,238   2 $1,619   $3,238 1
Sep 13, 2019 96 $65   1 $65   $5,627 6
Sep 20, 2019 88 $1,125 +1,631% 1 $1,125   $6,752 7

Weekly Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Aug 9, 2019 64 $5,562   2 $2,781   $5,562 1
Sep 13, 2019 104 $65   1 $65   $5,627 6

Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.


Synopsis

When a father struggling to keep custody of son, keep his business afloat and keep his own father alive, is given a chance to profit off of overseas pharmaceutical smuggling, he jumps at the chance. But what follows is one man’s profound evolution from what it is to make money to what it is to make a difference.

Metrics

Opening Weekend:$3,238 (48.0% of total gross)
Legs:2.09 (domestic box office/biggest weekend)
Domestic Share:0.0% (domestic box office/worldwide)
Theater counts:2 opening theaters/2 max. theaters, 2.0 weeks average run per theater
Infl. Adj. Dom. BO $8,815

Movie Details

Domestic Releases: August 9th, 2019 (Limited) by China Lion Film Distribution, released as Dying to Survive
International Releases: June 30th, 2018 (Wide) (China)
MPA Rating: Not Rated
Running Time: 96 minutes
Geographical setting: China, India
Plot point: Cancer, Medical and Hospitals, Pharmaceuticals, Smuggler, Terminal Illness
Source material: Inspired by a True Story
Subgenre: Comedy Drama
Source:Original Screenplay
Genre:Drama
Production Method:Live Action
Creative Type:Contemporary Fiction
Production/Financing Companies: Dirty Monkey Films Group, Huanxi Media Group Limited, Beijing Universe Starlight Culture Media Company, Beijing Talent International Film Co
Production Countries: China
Languages: Mandarin

Weekend Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Aug 9, 2019 61 $3,238   2 $1,619   $3,238 1
Sep 13, 2019 96 $65   1 $65   $5,627 6
Sep 20, 2019 88 $1,125 +1,631% 1 $1,125   $6,752 7

Weekly Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Aug 9, 2019 64 $5,562   2 $2,781   $5,562 1
Sep 13, 2019 104 $65   1 $65   $5,627 6

Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.